Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    KDOQI Clinical Practice Guideline for vascular access: 2019 update

    Lok, Charmaine E; Huber, Thomas S; Lee, Timmy; Shenoy, Surendra; Yevzlin, Alexander S; Abreo, Kenneth; Allon, Michael; Asif, Arif; Astor, Brad C; Glickman, Marc H; Graham, Janet; Moist, Louise M; Rajan, Dheeraj K; Roberts, Cynthia; Vachharajani, Tushar J; Valentini, Rudolph P.
    Am. j. kidney dis; 75 (4 supl. 3), 2020
    The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidencebased guidelines for hemodialysis vascular access since 1996. Since the last update in 2006, there has been a great accumulation of new evidence and sophistication in the guidelines process. The 201...
    Medicina Basada en la Evidencia, Soluciones para Hemodiálisis/normas, Dispositivos de Acceso Vascular, Insuficiencia Renal Crónica/terapia
    Texto completo

    KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update

    Am. j. kidney dis; 66 (5), 2015
    The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications since 1997. The 2015 update of the KDOQI Clinical Practice Guideline for Hemodialysis Adequacy is intended to...
    Insuficiencia Renal Crónica/terapia, Diálisis Renal/normas, Hemofiltración/normas, Factores de Tiempo, Enfoque GRADE
    Texto completo

    Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians

    Qaseem, A; Hopkins, RH Jr; Sweet, D. E; Starkey, M; Shekelle, P.
    Ann. intern. med; 159 (12), 2013
    DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
    Insuficiencia Renal Crónica/diagnóstico, Insuficiencia Renal Crónica/tratamiento farmacológico, Progresión de la Enfermedad, Triaje, Antagonistas de Receptores de Angiotensina/uso terapéutico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Antihipertensivos/uso terapéutico, Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico, Hipolipemiantes/uso terapéutico, Gemfibrozilo/uso terapéutico, Enfermedades Asintomáticas, Quimioterapia Combinada, Enfoque GRADE
    Texto completo